- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 193 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 245 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 195 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2025
- 192 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 94 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 144 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 136 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- May 2025
- 127 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- January 2025
- 120 Pages
United States
From €2230EUR$2,490USD£1,901GBP
- Report
- November 2023
- 30 Pages
United States
From €2463EUR$2,750USD£2,100GBP
- Report
- February 2024
- 85 Pages
North America
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 90 Pages
Europe
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 120 Pages
Global
From €4255EUR$4,750USD£3,627GBP

Bupivacaine is a local anesthetic drug used to numb a specific area of the body. It is commonly used in surgeries, dental procedures, and other medical procedures. It works by blocking the transmission of pain signals from the nerves to the brain. Bupivacaine is available in both injectable and topical forms. It is also available in combination with other drugs, such as epinephrine, to provide longer-lasting pain relief.
The bupivacaine market is a competitive one, with many companies offering different formulations of the drug. Companies in the market include Pfizer, Mylan, Teva Pharmaceuticals, and Sandoz. These companies offer a variety of bupivacaine products, including generic and branded versions. Additionally, some companies offer combination products, such as bupivacaine with epinephrine, to provide longer-lasting pain relief. Show Less Read more